Filter By Industry
Filter By Tag

Newsroom

Mentrik Biotech Press releases

1 - 2 of 2 Press Releases

Feb 10, 2012
New pre-clinical and clinical data on Mentrik Biotech’s ocaratuzumab, a humanized, next-generation anti-CD20 monoclonal antibody for treatment of follicular lymphoma, was released in Clinical Cancer Research, published by the AACR.

Feb 03, 2012
.Mentrik Biotech, LLC is pleased to announce the United States Adopted Name Council (USANC) and the World Health Organization’s International Nonproprietary Name (INN) program have adopted “ocaratuzumab” as the generic name for AME-133v.


Mentrik Biotech RSS Feed